What is Oncolytics Biotech Inc (ONCY) stock price today?

Oncolytics Biotech Inc (ONCY) currently trades at $0.88 per share. The stock has a market capitalization of $112.49M and a P/E ratio of —x.

Is ONCY stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Oncolytics Biotech Inc has a Smart Value Score of 16/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is -36.86.

Is Oncolytics Biotech Inc financially healthy?

Oncolytics Biotech Inc's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of -36.86 places it in the distress.

ONCY

Oncolytics Biotech Inc

NASDAQ: ONCY · HEALTHCARE · BIOTECHNOLOGY

$0.88

+1.03% today

Updated 2026-04-30

Market cap

$112.49M

P/E ratio

—

P/S ratio

58.60x

EPS (TTM)

$-0.30

Dividend yield

—

52W range

$0 – $2

Volume

1.1M

Market cap

$112.49M

P/E ratio

—

P/S ratio

58.60x

EPS (TTM)

$-0.30

Dividend yield

—

52W range

$0 – $2

Volume

1.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

3.0

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-36.9

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$5.15

+485.23%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -36.86 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-6.27M

- Debt/equity 7.26x — high leverage

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-19.08M	$-20.56M	$-31.71M	$-28.76M	$-1.51M
EPS	—	—	—	—	$-0.30
Free cash flow	$-23.41M	$-28.46M	$-27.20M	$-20.12M	$-6.27M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ONCY	$112.49M	16	4.3	3.0	5.0	3.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Oncolytics Biotech Inc trades at $0.88. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -36.86, it sits in the distress.

Frequently asked questions

What is Oncolytics Biotech Inc's stock price?

Oncolytics Biotech Inc (ONCY) trades at $0.88.

Is Oncolytics Biotech Inc overvalued?

Smart Value Score 16/100 (Grade F, Strong Sell).

What is the price target of Oncolytics Biotech Inc (ONCY)?

The analyst target price is $5.15, representing +485.2% upside from the current price of $0.88.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

-36.86 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

oncolyticsbiotech.com

Quick metrics

P/S ratio58.60x

ROE-769.00%

Beta0.99

50D MA$1.01

200D MA$1.07

Shares out0.12B

Float0.11B

Short ratio—

Avg volume1.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ONCY vs LLY →ONCY vs JNJ →ONCY vs ABBV →Stock screener →